AstraZeneca's Toprol XL First Once-Daily Beta Blocker Approved For CHF
AstraZeneca's Toprol XL (metoprolol) is the first beta blocker approved for once-daily use for treatment of congestive heart failure.
You may also be interested in...
Roche's acquisition of the anti-emetic Kytril from SmithKline Beecham will build on Roche's strength in the U.S. hospital market.
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials